EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

2024 The Royal College of Physicians of Thailand (RCPT) clinical practice guidelines on management of dyslipidemia for atherosclerotic cardiovascular disease prevention

Praween Lolekha, Weerapan Khovidhunkit, Chaicharn Deerochanawong, Nuntakorn Thongtang, Thananya Boonyasirinant, Chatchalit Rattarasarn, Aurauma Chutinet, Vuddhidej Ophascharoensuk, Nicha Somlaw, Surapun Sitthisook, Surajit Suntorntham, Wannee Nitiyanant und 1 weitere

Asian Biomedicine · 01.12.2024 · 18 (6) · 246-267

DOI: 10.2478/abm-2024-0033 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Asian Biomedicine, online erschienen am 16.12.2024. Verfasst von Praween Lolekha und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Thammasat University, Patrhumthani 12121, Thailand. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Royal College of Physicians of Thailand (RCPT) published a Clinical Practice Guideline on Pharmacologic Therapy of Dyslipidemia for Atherosclerotic Cardiovascular Disease (ASCVD) Prevention in 2016. The availability of newer classes of medications for dyslipidemia, supported by extensive clinical research findings, indicates a significant need for the updating of the existing clinical practice guideline.

Objectives

To serve as guidelines on the management of dyslipidemia for Thai adults.

Methods

The RCPT Dyslipidemia Guidelines Committee was established with representatives from selected professional societies to revise the 2016 Guideline by critically reviewing the latest evidence. Meetings were conducted from August to December 2023, culminating in a public hearing that engaged various stakeholders in January 2024. The final Thai version received approval in April 2024, while the English translation was completed in October 2024.

Results

Lifestyle modifications and statins remain the cornerstone of therapy for dyslipidemia in adults across various clinical settings. Emerging evidence regarding newer classes of lipid-lowering medications indicates that these treatments are effective in lowering LDL-cholesterol levels and reducing atherosclerotic cardiovascular events. This suggests that they may serve as an add-on therapy for individuals who cannot achieve target levels or who are at high risk for future cardiovascular events. The Thai CV Risk Score is recommended due to its specificity for the Thai population.

Conclusions

The 2024 updated clinical practice guidelines establish a framework, provide recommendations, and serve as a comprehensive resource for the contemporary management of dyslipidemia in adults, with the goal of preventing ASCVD in Thailand.

Schlagwörter

Stichwörter der Autor:innen

Thaiatherosclerosiscardiovascular diseasedyslipidemiaguideline

Autor:innen und Institutionen

  • Department of Medicine, Thammasat University, Patrhumthani 12121, Thailand.
  • Department of Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Medicine, Rajavithi Hospital and Rangsit University, Bangkok 10400, Thailand.
  • Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
  • Department of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

Zitieren

APA

Lolekha, P., Khovidhunkit, W., Deerochanawong, C., Thongtang, N., Boonyasirinant, T., Rattarasarn, C., Chutinet, A., Ophascharoensuk, V., Somlaw, N., Sitthisook, S., Suntorntham, S., Nitiyanant, W., & Krittayaphong, R. (2024). 2024 The Royal College of Physicians of Thailand (RCPT) clinical practice guidelines on management of dyslipidemia for atherosclerotic cardiovascular disease prevention. Asian Biomedicine, 18(6), 246-267. https://doi.org/10.2478/abm-2024-0033

Vancouver

Lolekha P, Khovidhunkit W, Deerochanawong C, Thongtang N, Boonyasirinant T, Rattarasarn C, et al. 2024 The Royal College of Physicians of Thailand (RCPT) clinical practice guidelines on management of dyslipidemia for atherosclerotic cardiovascular disease prevention. Asian Biomedicine. 2024;18(6):246-267. doi:10.2478/abm-2024-0033

BibTeX
@article{Lolekha2024,
  author = {Lolekha, Praween and Khovidhunkit, Weerapan and Deerochanawong, Chaicharn and Thongtang, Nuntakorn and Boonyasirinant, Thananya and Rattarasarn, Chatchalit and Chutinet, Aurauma and Ophascharoensuk, Vuddhidej and Somlaw, Nicha and Sitthisook, Surapun and Suntorntham, Surajit and Nitiyanant, Wannee and Krittayaphong, Rungroj},
  title = {2024 The Royal College of Physicians of Thailand (RCPT) clinical practice guidelines on management of dyslipidemia for atherosclerotic cardiovascular disease prevention},
  journal = {Asian Biomedicine},
  year = {2024},
  volume = {18},
  number = {6},
  pages = {246--267},
  doi = {10.2478/abm-2024-0033}
}
Kostenlos starten →